Completed PHASE4 INTERVENTIONAL 2-arm NCT00619593

Survival of Patients With Primary Prophylactic ICD Indication (SPIRIT-ICD)

Survival of Patients With Primary Prophylactic ICD Indication, Provided With Intensified Care After 1st ICD Therapy

Sponsor: Biotronik SE & Co. KG

Conditions Primary Prevention Sudden Cardiac Death Tachycardia, Ventricular

Interventions Intensified diagnostic and treatment measures following 1st appropriate ICD therapy Standard follow-up

Updated 6 times since 2017 Last updated: Jan 9, 2015 Started: Feb 29, 2008 Primary completion: Apr 30, 2014 Completion: Jul 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Primary Prevention and Sudden Cardiac Death and is currently completed. Biotronik SE & Co. KG leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biotronik SE & Co. KG

Data source: Biotronik SE & Co. KG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aachen, Germany , Bad Neustadt an der Saale, Germany , Banská Bystrica, Slovakia , Basel, Switzerland , Bielefeld, Germany , Bonn, Germany , Bratislava, Slovakia , Brno, Czechia , Budapest, Hungary , Debrecen, Hungary and 24 more locations